Johnson & Johnson Ordered to Pay $8 Billion in Case Involving Male Breast Growth
The company is accused of failing to adequately warn patients about the risks of the antipsychotic drug Risperdal.
The company is accused of failing to adequately warn patients about the risks of the antipsychotic drug Risperdal.